“Evolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia”
-
Published:2024-10
Issue:
Volume:107
Page:76-83
-
ISSN:0890-5096
-
Container-title:Annals of Vascular Surgery
-
language:en
-
Short-container-title:Annals of Vascular Surgery
Author:
Creeden Thomas,
Jones Douglas W.ORCID
Reference44 articles.
1. Surgery or endovascular therapy for chronic limb-threatening ischemia;Farber;N Engl J Med,2022
2. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial
3. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial;Hunt;Trials,2017
4. Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing;Granada;Open Heart,2014
5. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial;Gray;Lancet,2018